Understanding how individual amino acid residues drive binding, stability, and specificity is fundamental to rational protein engineering, drug design, and mechanistic biology. Our Residue Interaction and Hotspot Analysis Service dissects protein-protein, protein-ligand, and protein-nucleic acid interfaces at atomic resolution, combining per-residue energy decomposition, computational alanine scanning, hydrogen bond network mapping, hydrophobic patch identification, and mutation effect prediction into an integrated, decision-ready report that reveals which residues truly matter — and why.
We decompose the total binding free energy into contributions from individual residues using MM/PBSA, MM/GBSA, or free energy perturbation approaches, quantifying whether each amino acid stabilizes or destabilizes the complex.
Systematic computational alanine scanning evaluates the binding contribution of every interface residue by predicting the free energy change upon mutation to alanine, highlighting critical positions for experimental follow-up.
We map the complete network of hydrogen bonds, salt bridges, and water-mediated contacts across the interface, assessing bond geometry, occupancy persistence, and network connectivity to identify structurally critical interaction clusters.
Beyond polar contacts, we quantify hydrophobic packing, π-π stacking, cation-π interactions, and shape complementarity scores, capturing the full spectrum of forces that stabilize protein interfaces.
Using molecular dynamics trajectories, we evaluate how residue-level fluctuations, correlated motions, and conformational sampling affect interface stability, revealing positions that anchor or destabilize the complex.
We overlay sequence conservation scores, co-evolutionary coupling, and phylogenetic variation onto the interface structure, distinguishing functionally constrained residues from those tolerant to substitution.
End-point free energy methods that decompose total binding energy into per-residue contributions from molecular dynamics ensembles, balancing computational efficiency with mechanistic insight for medium-to-large interfaces.
For projects requiring the highest accuracy in mutation effect prediction, FEP and Thermodynamic Integration provide rigorous alchemical free energy differences through explicit simulation of the mutation pathway.
Empirical force-field-based scanning tools that rapidly evaluate the stability and binding effects of all 20 amino acid substitutions at each interface position, ideal for broad mutational landscape exploration.
Distance- and angle-based analysis of all inter-residue contacts using tools such as LigPlot+, PDBsum, and in-house scripts to generate comprehensive interaction fingerprints and 2D interface diagrams.
Graph-theoretic analysis of residue-level connectivity treats the interface as a network, enabling identification of hub residues, communication bottlenecks, and allosteric pathways through centrality metrics and community detection.
Rather than analyzing a single static structure, we compute interaction fingerprints across entire MD trajectories, capturing transient contacts, water-mediated interactions, and conformational dependencies that single-structure analysis misses.
We source experimental structures from the PDB, homology models, or client-provided coordinates, then perform structural quality checks, protonation state assignment, and missing loop/side-chain remediation before any analysis begins.
We computationally delineate the binding interface using solvent-accessible surface area change, distance cutoffs, and interaction criteria, then classify residues as core interface, rim, or supporting based on structural context.
Non-covalent interactions are exhaustively catalogued: hydrogen bonds, salt bridges, hydrophobic contacts, π-stacking, cation-π, and water-mediated bridges are identified with geometric validation and occupancy scoring.
Per-residue free energy contributions are computed via the selected method (MM/PBSA, MM/GBSA, FoldX, or FEP), and computational alanine scanning quantifies the predicted impact of removing each side chain on binding.
Molecular dynamics simulations sample conformational space, enabling RMSF-based flexibility assessment, dynamic contact persistence tracking, and identification of residues whose contribution depends on sampling time scale.
All analytical dimensions are synthesized into a unified hotspot prioritization, with residue-level ΔΔG rankings, interface network diagrams, mutation design suggestions, and clear experimental validation guidance.
| Research Question | Recommended Analysis Pipeline | Key Readouts | Decision Supported |
|---|---|---|---|
| Which residues drive the binding affinity of my complex? | MM/PBSA per-residue decomposition + alanine scanning | Per-residue ΔG ranking, hotspot classification, ΔΔG prediction | Prioritize residues for mutagenesis, affinity maturation, or inhibitor design |
| How does a disease mutation disrupt protein-protein interaction? | FoldX/Rosetta mutagenesis + interface contact analysis + MD | Predicted stability and binding ΔΔG, contact loss, dynamic perturbation | Explain pathogenic mechanism, design rescue or compensatory mutations |
| Which interface positions are conserved and functionally constrained? | Conservation analysis + RIN centrality + interaction fingerprinting | Conservation scores, network centrality metrics, contact persistence | Distinguish functional hotspots from structural scaffold residues |
| Can I identify allosteric communication pathways through the interface? | Residue interaction network modeling + dynamic cross-correlation | Centrality rankings, community structure, correlated motion maps | Map signal propagation, identify allosteric control points |
| Which antibody CDR residues most critically contact the epitope? | Paratope-epitope contact mapping + alanine scanning + MD fingerprinting | CDR contact inventory, paratope ΔG contributions, dynamic contact persistence | Guide antibody engineering, affinity maturation, and humanization |
| How does the interaction network differ between wild-type and mutant? | Comparative contact profiling + MD ensemble analysis + network rewiring | Differential contact maps, ΔΔG comparison, network topology change | Characterize mutation mechanism, design compensatory interface changes |
Identify which complementarity-determining region residues dominate epitope binding, predict the effect of CDR mutations, and prioritize positions for affinity maturation campaigns with residue-level guidance.
Characterize how clinically observed missense variants perturb protein-protein and protein-ligand interfaces, providing mechanistic explanations for loss-of-function, gain-of-function, or altered specificity phenotypes.
Map the energetic landscape of protein-ligand binding sites to determine which residues provide the strongest contributions, enabling fragment-based design, pharmacophore refinement, and selectivity optimization.
Understand which interface residues control binding specificity versus promiscuity, supporting the rational redesign of protein-protein interaction surfaces for altered partner preference or orthogonal binding.
Distinguish biological interfaces from crystal contacts, validate interface assignments with energetic criteria, and assess whether observed contacts in static structures persist under dynamic conditions.
Trace how binding or mutation at one site propagates structural and dynamic changes to distal functional sites through residue interaction networks and correlated motion analysis.
Standard interface tools can count contacts, but they do not tell you which residues energetically dominate binding, which mutations will matter, how dynamics reshape the interface, or where evolution has placed its constraints. Our service integrates multiple complementary analytical dimensions — energetic, structural, dynamic, and evolutionary — into a single, coherent picture that directly informs experimental design and engineering decisions.
Objective: identify 3–5 residues whose mutation is predicted to enhance antibody-antigen binding affinity by at least 2-fold.
Objective: explain how 10–20 clinically observed missense variants disrupt a multiprotein complex assembly.
Objective: identify residues that confer binding specificity for one protein family member over closely related paralogs.
Standard docking predicts whether and how two molecules bind as a whole, typically returning a single score per pose. Residue interaction analysis goes deeper — it decomposes that binding into individual amino acid contributions, revealing which specific residues drive affinity, which form structural scaffold contacts, and which are dispensable. This residue-level information is essential for rational mutagenesis and engineering.
Computational alanine scanning methods — particularly those based on MM/PBSA and FoldX — generally achieve correlation coefficients of 0.6–0.8 with experimental ΔΔG values, depending on the system, method, and conformational sampling depth. For critical design decisions, we recommend using multiple complementary methods and, where possible, benchmarking against any available experimental data for your system or closely related complexes.
Yes, provided a sufficiently accurate model is available. We can work with high-confidence homology models, AlphaFold-predicted complexes, or docking-generated poses. However, analysis quality depends on model accuracy — we always assess input structure quality and communicate uncertainty associated with modeled structures. Better inputs yield more reliable hotspot predictions.
We routinely analyze protein-protein, protein-peptide, protein-DNA, protein-RNA, antibody-antigen, and protein-small molecule interfaces. Multimeric complexes, homo- and hetero-oligomers, and multi-chain assemblies are all within scope. For very large assemblies or membrane-embedded complexes, we adjust the computational strategy accordingly.
Turnaround time depends on the analysis depth. A focused alanine scanning and per-residue energy decomposition for a single complex typically requires 1–2 weeks. Projects incorporating MD simulation for dynamic validation, FEP for high-accuracy mutation effects, or comparative analysis across multiple complexes may extend to 3–4 weeks. We provide timeline estimates during project scoping.
Yes. We can incorporate phosphorylation, acetylation, ubiquitination, glycosylation, and other PTMs into our analysis pipeline. Modified residues are parameterized appropriately, and the energetic and structural impact of the modification on the interface is explicitly evaluated against the unmodified state.
Share your complex of interest — whether it is an antibody-antigen pair, a signaling complex, a drug-target interaction, or a disease-associated protein assembly. Our team will design a tailored residue interaction analysis plan and deliver actionable, residue-level insights for your next experimental or engineering step.
Submit Your Project DetailsSubmit your project details below, and our team will respond within 24 hours.
Talk to our technical team about your project!
I Want To Talk